In the multivariate Cox regression model, high CD9 expression was associated with a hazard ratio (HR) of 1.28 (95% confidence interval [CI]: 1.03–1.58), indicating that elevated CD9 expression serves as a significant risk factor for glioma (p < 0.026) (Table 1). Here, CD9 is linked to central nervous system cancer.